June 19, 2018

The quarterly specialty drug list is now available. No new drugs were added to the list for this quarter. The following drugs were removed:

  1. Antipsychotics, Long-Acting Injectable
    • aripiprazole (Abilify Maintena)
    • aripiprazole lauroxil (Aristada ER)
    • paliperidone palmitate (Invega Sustenna and Invega Trinza)
    • Olanzapine (Zyprexa Relprevv)
    • Risperidone (Risperdal Consta)
  2. Cystic Fibrosis
    • dornase alfa (Pulmozyme)
  3. Growth Hormones
    • somatropin, E-Coli or mammalian derived (Genotropin, Genotropin Miniquick, Norditropin Flexpro, Omnitrope, and Saizen)
  4. Immune Serum
    • Rho (D) Immune Globulin (HyperRHO S/D or mini-dose S/D)
  5. HIV Infection
    • enfuvirtide (Fuzeon)
    • nevirapine (nevirapine oral suspension generic only)
    • ritonavir (Norvir soft gel)
    • zidovudine syrup (Retrovir syrup)
  6. Infantile Hemangioma
    • propranolol (Hemangeol) oral solution
  7. Blood Modifier Agents
    • eltrombopag olamine (Promacta)
    • TBO-filgrastim (Granix)
    • sargramostim (Leukine)
  8. Endocrine and Metabolic Agents
    • lipase/protease/amylase (Pancrelipase 5000)
    • Lanreotide (Somatuline Depot)